Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015

BACKGROUND: Disease modifying treatments (DMTs) are the main responsible for direct medical costs in multiple sclerosis (MS). The current investigation aims at evaluating possible associations between healthcare costs for treating relapsing remitting MS (RRMS) and disease evolution. METHODS: The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Moccia, Marcello, Palladino, Raffaele, Lanzillo, Roberta, Carotenuto, Antonio, Russo, Cinzia Valeria, Triassi, Maria, Brescia Morra, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215923/
https://www.ncbi.nlm.nih.gov/pubmed/28056103
http://dx.doi.org/10.1371/journal.pone.0169489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215923/
https://www.ncbi.nlm.nih.gov/pubmed/28056103
http://dx.doi.org/10.1371/journal.pone.0169489

Ejemplares similares